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A B S T R A C T   
Sulfide oxidation is catalyzed by ancient membrane-bound sulfide:quinone oxidoreductases (SQR) which are 
classified into six different types. For catalysis of sulfide oxidation, all SQRs require FAD cofactor and a redox- 
active centre in the active site, usually formed between conserved essential cysteines. SQRs of different types 
have variation in the number and position of cysteines, highlighting the potential for diverse catalytic mecha-
nisms. The photosynthetic purple sulfur bacterium, Thiocapsa roseopersicina contains a type VI SQR enzyme 
(TrSqrF) having unusual catalytic parameters and four cysteines likely involved in the catalysis. Site-directed 
mutagenesis was applied to identify the role of cysteines in the catalytic process of TrSqrF. Based on biochem-
ical and kinetic characterization of these TrSqrF variants, Cys121 is identified as crucial for enzyme activity. The 
cofactor is covalently bound via a heterodisulfide bridge between Cys121 and the C8M group of FAD. Mutation of 
another cysteine present in all SQRs (Cys332) causes remarkably decreased enzyme activity (14.6% of wild type 
enzyme) proving important, but non-essential role of this residue in enzyme catalysis. The sulfhydril-blocking 
agent, iodoacetamide can irreversibly inactivate TrSqrF but only if substrates are present and the enzyme is 
actively catalyzing its reaction. When the enzyme is inhibited by iodoacetamide, the FAD cofactor is released. 
The inhibition studies support a mechanism that entails opening and reforming of the heterodisulfide bridge 
during the catalytic cycle of TrSqrF. Our study thus reports the first detailed structure-function analysis of a type 
VI SQR enzyme which enables the proposal of a distinct mechanism of sulfide oxidation for this class.   
1. Introduction 
Sulfur is one of the most crucial elements for living organisms. Its 
most reduced and reactive form, sulfide (H2S. HS− , S2− ) is toxic to cells 
primarily due to inhibition of hemoproteins involved in electron trans-
port chains (e.g., cytochrome c oxidase) [1–3]. Despite its toxicity, sul-
fide is an essential metabolite during the biosynthesis and catabolism of 
important sulfur-containing cellular compounds, such as methionine, 
cysteine and iron-sulfur clusters [4]. Besides, it can also be an energy 
and electron donor for microorganisms living in sulfide-rich environ-
ments [5,6]. In eukaryotes, sulfide and its derivatives are recognized as 
cell modulators and signal molecules, participating in diverse 
physiological processes, similarly to the other gasotransmitter com-
pounds, such as nitric oxide (NO) and carbon monoxide (CO) [7–9]. 
Inappropriate control of sulfide concentration is associated with various 
pathological processes, such as neurodegenerative diseases, cancer, and 
diabetes [10,11]. 
Sulfide:quinone oxidoreductases (SQR) are ancient monotopic 
membrane-bound flavoproteins, which were essential for the early life 
forms living in the sulfidic oceans of the primordial Earth [12,13], and 
now ubiquitous in all organisms except plants [5,6]. SQR enzymes 
belong to the Flavoprotein Disulfide Reductase (FDR) enzyme family 
[14] acting on the most reduced form of sulfur (sulfide), thus offering a 
first crucial step to detoxification. SQRs catalyze the oxidation of sulfide 
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to sulfur via electron transfer to the membrane quinone pool in micro-
organisms and mitochondria. In addition to a role in sulfide detoxifi-
cation, SQRs can be involved in sulfide-dependent bioenergetics and 
eukaryotic sulfide homeostasis. 
SQR proteins have been classified into six types (types I–VI, SqrA–F), 
each with characteristic sequence motifs and structural elements [12] 
(Fig. 1). More recently, a thorough bioinformatic analysis of all available 
SQR sequences has also distinguished six classes and recognized a new 
group of essentially archaeal SQRs [6]. The later study excludes the 
previously identified type VI subfamily discounting it as a sulfide: 
quinone oxidoreductase type based on the required sequence criteria. 
However, in this study, we follow the classification of Marcia et al. [24]. 
The biochemical, enzymatic, and structural characterization of SQR 
enzymes has been limited by the difficulties in their isolation in a stable, 
active form from their natural host [15,16] or via heterologous protein 
expression [17–23] in, for example, E. coli. The SQR enzymes catalyze a 
complex redox reaction composed of reductive and oxidative half- 
reaction. Similarly to all members of FDR enzyme family, for the 
catalysis, SQR enzymes require Flavine Adenine Dinucleotide (FAD) 
cofactor and a redox-active disulfide bridge usually formed between the 
conserved internal cysteines in the active centre of the enzyme 
[12,22,24–26]. The reductive phase combines the reduction of FAD with 
the oxidation of sulfide resulting in the formation of cyclooctasulfur 
rings or polysulfide chains of sulfur atoms. The polymerization of the 
oxidized sulfide substrate molecules requires the contribution of the 
redox-active disulfide bridge. The second oxidative half reaction is 
simpler, in which electrons are transferred from the reduced FAD to the 
electron acceptor; a quinone compound in the membrane [27]. 
Primary sequence comparison of SQRs reveals the presence of 
cysteine residues in the proteins, conserved at various levels across the 
various types [12]. Furthermore, site-directed mutagenesis studies have 
indicated their importance in the catalytic activity of these enzymes. 
Cysteines, corresponding to the Cys347 residue of Aquifex aeolicus type I 
SQR, are present in all known SQR proteins and also cysteines corre-
sponding to Cys156, except for type VI enzymes (Fig. 1). Single point 
mutations of these cysteines to serine or alanine in the type I SQR of 
Rhodobacter capsulatus and Acidithiobacillus ferrooxidans resulted in 
drastically reduced activity and/or inactive proteins [17,18], indicating 
their essential role in the catalytic function of SQR enzymes. A third 
cysteine, Cys124, is also highly conserved, but is absent in type II, type 
III and few type V SQR proteins. Its essential role in type I SQRs is 
highlighted by the drop of activity to approximately 1% of the wild-type 
enzyme upon its replacement by serine [17]. Interestingly, type VI SQR 
proteins have a slightly different set of conserved cysteines across all 
known representatives that therefore appear to be characteristic of this 
set. This difference will be discussed further later. 
So far, the crystallographic structures of two type I SQRs [18,24,26], 
one type II SQR [22] and a type V SQR [25] have been determined. 
Based on the known SQR crystallographic structures, the conserved 
cysteines are located in the active centre of the enzymes near to the 
isoalloxazine ring of FAD cofactor. The relative position of the conserved 
cysteines in the various SQR proteins is schematically represented on the 
right-side panel of Fig. 1. The SQR structures (for the group I, II and V 
SQRs) revealed that a redox-active disulfide-bridge is formed by two 
conserved cysteines close to FAD located at the active site, which 
contain the residues corresponding to Cys156 and Cys347 of A. aeolicus 
SQR [22,24–26]. 
The FAD cofactor is bound either covalently or non-covalently to the 
A. ferrooxidans NPWVGVGWK SIC-TVDH -MAGASCF-GPAYE FVLVDEHQ- NAVCFADMGD
Type I R. capsulatus NPWVAVGWR SIC-HIDH -AQGASCF-GPAYE  FVIVDQHQ- NAVCLADFGD
A. aeolicus FPHLAMGWR SIC-TAEH -IPGVSCF-GPAYE  MVIVNRCF- SAICIADFGE
C124 C156 C347
H. sapiens WTLVGAGAK SNY-SVKT PNTPVKCA-GAPQK WVDVDKETL  YTSCPLVTGY
Type II Synechocystis sp. WTLVGGGAF SNY-DRRY PATPIKCA-GAPQK WVDVDKFTL  YTCCPLVTGY
S. pombe WTLTGAGLS TIY-SEKY PSGVLKCA-GAPQK FVAVDQSTT   YTSCPLLTGY
S. solfataricus QLLVGFGLE TVY-EYDD AKLPHRCP-VAPLE WVPTDKFTL  DVLCYIATGT
Type III C. tepidum LLFVPFGVQ TFY-YKEA AELPFKCP-VAPIE YVPTHHNTL  HSTCFIVYSK
C. maquilingensis LLYIAFKGS YHS-SEEN SYERYRCP-PSPLE   FVLADNATN  RTHCPFDMGY
A. vinosum NIWVGVGEM  SVC-TPSH GHGMCTCQ-GAAFE  FMKVDADYN   GAACVASTGM
Type IV S. denitrificans NIWVGVGEM SVC-TADH GHGLCTCQ-GAAFE  FMKVDANYS  GAACVASAGK
C. tepidum NIWVGVGHM SVC-TYSH GHAMATCQ-GAAFE  FMKVDADYT  GAACIVSAGF
A. ambivalens LPHVAIGVR  SVC-EPEF PNADSACE-GPVFE FIPTDLNMV  TIMCVADNPY
Type V S. solfataricus LPHVATGVI  SVC-ELDY PVADAACE-GPIFE FVPTDLNMV  TIICVADNPF
C. tepidum ILMEILENK TVS-DGFY PMAKAACE-GPPVE  FVITNKQLK  EVICYGDMGD
C. tepidum AIWIPVGTE     SICGAPEH     --DPSAVRGGPGFE     FVKIDDFCR     NVLCVMDTGD
Type VI A. vinosum LIWVPSGLR  VPCEGVVA --EPSSMRGGPVFE   LLQADAHCR  ELLCIVDTND
T. roseopersicina LIWVPCGIR TPCEGIAA --EPSSMRGGPIFE   LLQADAHCR  ELVCIVDAND












Fig. 1. Multiple sequence alignment of selected representative SQR proteins with conserved cysteines in the primary sequence of various sulfide:quinone oxido-
reductases (Aquifex aeolicus and Thiocapsa roseopersicina residue numbering). The diagrammatic scheme (far right) indicates the approximate location of conserved 
cysteines in relation to the isoalloxazine ring of FAD, based on the structures of various sulfide:quinone oxidoreductases. 
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active site of the protein. A covalent bond is formed between the thiol 
group of homologues of the Cys124 residue of A. aeolicus and the C8M 
methyl group of the isoalloxazine moiety. Crystal structures show that in 
the type V SqrE enzyme of Acidianus ambivalens, a stable thioether bond 
is formed [25], but in the type I SqrA enzyme of A. aeolicus, a putative 
persulfide bond provides the link between the protein and the cofactor 
[24]. The FAD is bound non-covalently in the type I A. ferrooxidans and 
R. capsulatus SqrAs [17,26], the type II human SQR [22] and the type III 
SqrC of the hyperthermophilic archaeon, Caldivirga maquilingensis [19]. 
The mechanisms of the SQR-catalyzed reactions are poorly under-
stood. The aforementioned variations of the conserved cysteine patterns 
(see Fig. 1) and the chemical nature of FAD-binding indicate that there 
may also be differences in their catalytic mechanisms. The proposed 
requirement of the disulfide bridge formed between two conserved 
cysteines during the reductive phase has some support from structural 
and biochemical studies. It is suggested that the dissociated H2S (SH− ) 
initially reacts with the disulfide bridge formed by cysteines (between 
Cys156 and Cys347 in the A. aeolicus SqrA) through a nucleophilic 
attack mechanism. This reaction breaks up the disulfide bond generating 
a reduced thiolate form of one cysteine and promotes the formation of 
the intermediate charge-transfer complex between the other cysteine 
and the isoalloxazine ring of FAD. In the case of the “C4A mechanism”, 
the charge transfer complex uses the C4A carbon of the FAD isoalloxa-
zine ring either directly or by the incorporation of an additional sulfur 
(partially oxidized sulfide substrate) into the protein-FAD complex 
[17,18,22,24–26,28]. In an alternative model, the “C8M mechanism” 
described for the A. aeolicus SqrA enzyme, the redox-active disulfide 
bridge is formed between Cys124 and Cys156, and the consequent 
charge transfer complex involves Cys124 and the C8M group of the 
isoalloxazine moiety of FAD [24]. After the oxidation of FAD, a transient 
Cys124-S-S+ is formed which reacts with the Cys156-S− yielding a 
trisulfide bridge. The Cys347 takes over the growing sulfur chain, thus 
regenerating Cys156-S− for the next cycle. The catalytic cycle repeats 
multiple times, forming a ring or linear chain of sulfur (octasulfur ring or 
polysulfide) [12]. 
Thiocapsa roseopersicina, a model organism of photosynthetic purple 
sulfur bacteria, utilizes various reduced inorganic sulfur compounds (e. 
g. sulfide, sulfur, thiosulfate, sulfite) as electron and energy sources for 
its anoxygenic photochemolioautotrophic growth [29,30]. The bacte-
rium has complex sulfur metabolism for the oxidizing and/or reducing 
sulfurs of various oxidation states [31,32]. In the genomic sequence of 
T. roseopersicina [33], genes of two SQR enzymes of types IV and VI 
SQRs, SqrD and SqrF, respectively, were discovered [16]. The genes 
coding for another sulfide oxidase enzyme complex, flavocytochrome c 
sulfide dehydrogenase (Fcc), were also identified which interestingly 
has a sulfide-oxidizing subunit homologous to SQR enzymes (Balogh 
et al., personal communication) [16]. In the TrSqrF protein, there are 
four cysteine residues, which are likely involved in the catalytic cycle. 
Previous biochemical analysis of homologously-expressed and puri-
fied recombinant TrSqrF enzyme demonstrated that the protein contains 
a covalently bound FAD cofactor [16], in common with some other 
SQRs. The kinetic parameters of the enzyme, however, are different 
from those of any other characterized SQRs [16]. The catalytic mecha-
nism of type VI sulfide:quinone oxidoreductases has not been charac-
terized yet. 
In the study presented here, we perform a functional investigation of 
TrSqrF cysteine residues and propose a novel mechanistic model for 
catalysis of type VI sulfide:quinone oxidoreductases. 
2. Materials and methods 
2.1. Bacterial strains, plasmids, primers and nucleotide sequences 
Bacterial strains [16,34], plasmids [16,35,36] and PCR primers used 
are listed in Tables S1, S2 and S3, respectively. Nucleotide sequence data 
are available in the GenBank database under the accession numbers 
KY595104 (sqrD), KY595105 (sqrF), KY595103 (fccAB). 
2.2. Growth conditions 
E. coli and T. roseopersicina cells were grown as described in Duzs 
et al. [16]. 
In brief, E. coli cells were grown in Luria-Bertani Broth medium with 
25 μg/mL kanamycin or 100 μg/mL ampicillin. T. roseopersicina strains 
were grown photoautotrophically in modified Pfennig’s medium con-
taining 4 g/L sodium thiosulfate [37] supplemented with genotype- 
specific antibiotics (streptomycin: 25 μg/mL, gentamycin: 25 μg/mL, 
kanamycin: 25 μg/mL) under anaerobic conditions. The T. roseopersicina 
cultures were incubated at 25 ◦C for 4 days under illumination. 
2.3. Construction of fcc, sqrD and sqrF deletion mutant T. roseopersicina 
strain 
In order to delete the sqrD gene, the upstream region of the sqrD gene 
was amplified with the osqr1F–osqr2R primer pair using a Phusion po-
lymerase. The amplicon was treated with kinase and ligated into an 
EcoRV-digested Bluescript vector (creating pSQRUP). The sqrD upstream 
fragment was cleaved with EcoRI and BamHI from the pSQRUP and 
inserted into EcoRI-BamHI-digested pK18mobsacB (pKSQRUP). The 
downstream region of sqrD gene was amplified with the osqr3F-osqr4R 
primers and inserted into an EcoRV-digested Bluescript vector 
(pSQRDO). The pSQRDO and the pKSQRUP vectors were cleaved by 
XbaI-HindIII and the sqrD downstream region was ligated into the XbaI- 
HindIII digested pKSQRUP vector (pKDSQR). The pKDSQR plasmid was 
transformed into a conjugation-helper E. coli S17-1 λpir strain, then 
conjugated [38] into T. roseopersicina FOX (see Table S1) cells (FOQR). 
The construction of the sqrF gene deletion was carried out as described 
in Duzs et al. [16], and the pKDSQN was conjugated into 
T. roseopersicina FOQR cells resulting in the FOQRON strain. 
2.4. Construction of vectors expressing TrSqrF mutants 
In order to construct the mutant TrSqrF-expression vectors, the wild 
type TrsqrF gene in pBNSQNNS [16] plasmid was used as a template for 
site-directed mutagenesis. The reaction mix contained 20 ng template, 
200 μM dNTP, 10× Phusion HF buffer and 125–125 ng of the muta-
genesis primer pairs (onC121AF-onC121AR; onC272AF-onC272AR; 
onC332AF-onC332AR; onC49AF-onC49AR) in 50 μL total volume. 
DNA amplification with these primers was initiated by the addition of 
2.5 U Phusion DNA polymerase. The applied program was as follows: 1×
(30 s at 95 ◦C), 16 times: (30 s at 95 ◦C, 1 min at 55 ◦C), then 1× (6 min 
at 72 ◦C). DpnI (10 U/μL) was added into the reaction and incubated at 
37 ◦C for 1 h; then the reaction mix was transformed into XL1-Blue MRF′
cells. Selected clones were sequenced to confirm the successful mutation 
of the sqrF gene. Vectors containing the mutant sqrF fragments 
(pBNSQNNSC121A; pBNSQNNSC272A; pBNSQNNSC332A; 
pBNSQNNSC49A) were cleaved by HindIII, the ends were polished by 
Klenow enzyme and cleaved by NdeI endonuclease. The pDSK6CrtKm 
expression vector was digested by PstI, blunted using T4 DNA poly-
merase and cleaved by NdeI; then the mutant sqrF fragments were 
inserted into this vector (pDSQNNSC121A; pDSQNNSC272A; 
pDSQNNSC332A; pDSQNNSC49A). The expression vectors were conju-
gated (Fodor et al. 2001) into the T. roseopersicina FOQRON strain via 
the appropriate E. coli S17-1 lambda pir cell line, resulting in the strains 
named according to mutation: TrC121A; TrC272A; TrC332A; TrC49A, 
respectively (see also Tables S1 and S2). 
2.5. Expression and purification of TrSqrF protein variants 
T. roseopersicina cultures expressing TrSqrF mutants were grown in 
modified Pfennig’s medium in 2 L flasks at 25 ◦C for 4 days. Cells were 
centrifuged at 8300 ×g at 4 ◦C for 10 min. In order to eliminate the 
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periplasmic cell fractions, harvested cells were suspended in the peri-
plasmic buffer (150 mM NaCl, 50 mM Tris pH = 8.0, 25% sucrose and 
0.1% lysozyme) and incubated at 30 ◦C for 30 min. An equal volume of 
cold distilled water was added, and the cells were incubated on ice for 
10 min. After centrifugation (13,700 ×g; 4 ◦C, 10 min), the periplasmic 
fractions were discarded, the spheroplasts were suspended in TBS buffer 
(150 mM NaCl, 50 mM Tris pH = 8.0). To disrupt the spheroplasts, the 
suspensions were sonicated for 15 s 8 times applying 7 kJ energy on ice 
(Bandelin Sonoplus HD3100) and centrifuged (27,000 ×g, 4 ◦C, 15 min). 
The resulting crude cell extracts were ultra-centrifuged (Sorwall WX 
Ultra Series) (100,000 ×g, 4 ◦C, 90 min), and the pellet (membrane 
fraction) was suspended in TBS buffer. The membrane fractions were 
treated with 10 mM EDTA (pH =8.0) for 30 min at 25 ◦C, followed by 
addition of 1.45 M sodium-bromide and were further incubated at 25 ◦C 
for 60 min. The treated membrane fractions were ultra-centrifuged 
(200,000 ×g, 4 ◦C, 120 min), and the supernatant containing the 
TrSqrF variants were stored at − 20 ◦C. Recombinant, mutant TrSqrF 
proteins were purified via StrepII tag using Strep-Tactin Superflow high 
capacity resin at room temperature based on the instructions of the 
manufacturer (IBA Lifesciences, Cat. No.: 2-1208-002). 
2.6. Protein analytical methods 
The purified TrSqrF mutants were analyzed on 12% SDS- 
polyacrylamide gels [39]. Protein (1 μg of protein/sample) was loaded 
onto denaturing gels, and the bands were visualised by Blue Silver dye 
[40]. For western blotting, Strep-Tag II specific monoclonal antibody 
(IBA Lifesciences) was applied, and chemiluminescent detection was 
carried out using the SuperSignal West Pico Rabbit IgG Detection Kit 
(Thermo Scientific). The TrSqrF protein bands and signals were recor-
ded by the VersaDoc 4000MP gel-imaging system (BIO-RAD). For 
determination of the molecular weight of the purified proteins, Prosieve 
Quadcolor Protein Marker was used (cat. no.: 00193837). The concen-
trations of purified TrSqrF protein variants were determined using the 
Lowry method [41]. 
2.7. Spectroscopic assays 
The UV–visible absorption spectra of the purified proteins were ob-
tained by placing samples in a quartz cuvette and recording the absor-
bance over a wavelength range of 300–600 nm using a 
spectrophotometer (Nicolet Evolution 300, Thermo Scientific). Ab-
sorption spectra of the TrSqrF mutants of various concentrations were 
normalized so, that the maximum absorbance values of the spectra were 
the same. 
2.8. Enzyme activity assay 
Sulfide-dependent quinone reduction activity of the TrSqrF variants 
was measured in Suba-seal septa (Sigma-Aldrich) sealed, nitrogen- 
flushed quartz cuvettes under anaerobic conditions. For standard ac-
tivity measurements, 50 mM Tris-HCl buffer, pH = 8.0, 50 μM dur-
oquinone and 3.3 μg purified enzyme were combined in a 1 mL final 
volume. The reduction of duroquinone (molar extinction coefficient at 
275 nm: 16 mM− 1 cm− 1) [42] was recorded at 275 nm at 25 ◦C using a 
spectrophotometer (Nicolet Evolution 300, Thermo Scientific) immedi-
ately after addition of 200 μM anaerobically and freshly prepared sulfide 
to the reaction mix. The kinetic constants were determined using various 
concentrations of duroquinone (10–100 μM). The sulfide dependence of 
the mutant TrSqrF activities was measured in the 50–750 μM concen-
tration range. The data were curve-fitted by non-linear regression 
analysis of MatLab software [43]. One unit of sulfide:quinone oxidore-
ductase activity was defined as the amount of enzyme that achieves the 
reduction of 1 μmol duroquinone per min. At least three independent 
experiments were performed and evaluated. 
2.9. Enzyme inhibition assay 
Inhibition of TrSqrF enzyme activity by iodoacetamide was per-
formed as a standard activity measurement in the presence of sulfide and 
duroquinone and using 25–250 μM iodoacetamide. To study the 
connection between the inhibition of enzyme activity and flavin bind-
ing, 25 μM TrSqrF was mixed with 50 μM duroquinone and 200 μM 
sulfide in the presence or absence of 500 μM iodoacetamide and incu-
bated at room temperature for 10 min. Samples were taken for activity 
measurement from the mixtures, and the remaining reaction mixes were 
diluted 10 times to record the UV–visible absorption spectrum of the 
treated TrSqrF. The enzyme was precipitated with 5% trichloroacetic 
acid and centrifuged (4500 ×g, 4 ◦C, 15 min,) [44]. The absorption 
spectra of the supernatants and the pellets suspended in 0.25 mM NaOH 
were recorded by a spectrophotometer (Nicolet Evolution 300, Thermo 
Scientific). To determine the presence of unbound FAD, the suspended 
pellets were filtered through a 10 kDa Amicon Ultra centrifugal filter 
(Millipore) and the absorption spectra of filtrates documented. 
2.10. TrSqrF homology model 
For homology building, the Prime [45,46] module of the Schrodinger 
[47] suit was applied. Templates for homology modelling were found by 
a BLAST [48,49] search, and the A chains of three structures of SqrE and 
SqrA enzymes of A. ambivalens and A. aeolicus, respectively, were 
selected for model building (3H8L, 3HYW and 3HYV). The BLAST 
similarity for these structures gave identity values of 41.4, 39.8 and 
39.5, respectively. The use of multiple templates for homology model-
ling was necessary, as a protein complex with high similarity and con-
taining both ligands (FAD and dUQ) was not available in the PDB 
database. The initial model was based on the 3H8L, and the structure of 
the missing C-terminal part was predicted with the help of 3HYV. 
Modelling the position of dUQ required the use of 3HYW template. In 
Prime, energy-based homology building was selected, which resulted in 
a single homology model. Loop refinement was also performed where 
unrealistic close contacts were provided. Although the model was 
energy-minimized during the homology building, the resulting structure 
was minimized once again by the Macromodel [50] module using 
OPLS2005 force field with implicit solvent providing a proper covalent 
bond structure between Cys121 amino acid and the FAD cofactor. 
The model with the persulfide bond connection was derived from the 
single sulfur connected model. The second sulfur atom was considered 
as it might be present at a distance suitable for disulfide bond formation. 
We thus positioned the S atom of this cysteine according to this 
requirement. This starting position was minimized again with the 
Macromodel [50] package. 
3. Results 
3.1. Sequence comparison and structural homology model of TrSqrF 
According to the classification of Marcia et al. [12], the 
T. roseopersicina TrSqrF protein belongs to the type VI SQRs [16]. We 
aimed to disclose the catalytic mechanism of this type VI representative 
enzyme. To identify residues that participate in the catalytic process, a 
deep interrogation of sequence databases was performed. Residues of 
particular interest are cysteines due to their participation in the catalytic 
mechanism of SQRs of other types. The TrSqrF has four cysteines in the 
primary sequence (Fig. 1). Cys332 is ubiquitous, while Cys 121 is 
identified in type I, IV, V and VI SQRs and they correspond to the highly 
conserved Cys347 and Cys124 of A. aeolicus SQR, respectively. How-
ever, there is no matching residue to the Cys156 of A. aeolicus enzyme in 
the T. roseopersicina and all other type VI SQR proteins. The Cys272 is a 
unique, characteristic conserved cysteine of the type VI SQRs. Based on 
the available SQR structures, the corresponding amino acids of this 
cysteine in type I and type V SQR proteins are localized in a surface loop 
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[24–26]. The TrSqrF also contains a cysteine residue (Cys49) which is 
not conserved within any SQR type (Fig. 1). 
In the absence of a crystal structure for TrSqrF, which would support 
a mechanistic study of the enzyme, a homology model was built for this 
type of SQR enzyme. Details of the computations are presented in the 
Materials and Methods section. The primary sequence of TrSqrF [16], its 
FAD cofactor as well as decylubiquinone (dUQ) ligands were also 
incorporated in the model building where dUQ was taken in its keto 
form. The conserved cysteine, Cys121 (Cys 124 in A. aeolicus 
numbering) is an obvious candidate for participation in catalysis, since 
its homologues residue present in other SQRs except for type II, type III 
and some members of type V SQR enzymes. In the case of few SQRs, this 
residue has been shown as an essential amino acid forming a covalent or 
non-covalent association with FAD and/or with one of the other 
conserved cysteines in the active centre [24,25]. The nature of covalent 
linkage to the FAD is still subject to debate in the literature. In our 
modelling, we considered the interaction as a permanent covalent bond 
[16]. The possibility of a persulfide linkage to FAD was also investigated 
(Fig. S1). Based on the energy-minimized structural model of TrSqrF, we 
analyzed the model for mechanistic possibilities with regards to reduc-
tion of FAD and its re-oxidation upon final electron transfer to dUQ. The 
distances of the Cys residues in the TrSqrF model were found as follows: 
Cys121-Cys332: 13.08 Å; Cys121-Cys49: 15.37 Å; Cys332-Cys49: 18.39 
Å; Cys121-Cys272: 21.99 Å and Cys332-Cys272: 18.5 Å. These long 
distances raise the possibility that there is no a cysteine pair close 
enough to each other to form a direct disulfide bond, apparently 
excluding formation of such a bridge during catalysis by this enzyme 
(Fig. 2). So, according to our computational model, Cys121 can be 
positioned in the catalytic centre, with close contact between its sulf-
hydryl group and the C8 methyl group of FAD (1.82 Å). Cys332 could 
also be found fare away (5.81 Å) from the C4 atom of the FAD 
isoalloxazine ring. The third conserved cysteine, Cys272, a putative 
candidate to fulfil the role of the missing conserved Cys156 (A. aeolicus 
numbering), is far from the catalytic centre in our model. It is located 
within a flexible loop, and its thiol group is on the protein surface. The 
non-conserved Cys49 is also positioned close to the TrSqrF surface 
(Fig. 2). Considering the limitations of homology building, and regard-
less of their position in the structural model, all four cysteines in TrSqrF 
were selected for further biochemical investigation of their potential 
roles in the catalytic mechanism of type VI SQR enzymes. 
3.2. Expression and purification of single cysteine mutant TrSqrF variants 
Site-directed mutagenesis was applied for determining the role of 
each cysteine of TrSqrF in the catalytic mechanism. Single cysteine-to- 
alanine mutants were generated by quick change mutagenesis. 
The TrSqrF mutants were expressed by crtD promoter-driven 
expression vectors [51] previously utilized for the production of the 
wild type enzyme [16]. The TrSqrF variants were expressed in sqrD, sqrF 
and fccAB triple deletion mutant T. roseopersicina (FOQRON) strain 
lacking the wild type sulfide:quinone oxidoreductases and fla-
vocytochrome c. Based on western-blot analysis using Strep-tag II spe-
cific antibody, the expressed TrSqrF mutants were in the membrane 
fraction (data not shown) and produced at yields similar in the wild-type 
enzyme excepting the C121A mutant protein. After purification of 
membrane-bound proteins as described earlier [16], every of the TrSqrF 
variant appeared as single band with a molecular weight of approxi-
mately 44 kDa in SDS-PAGE analysis thus proving that the mutant 
proteins were purified to homogeneity (Fig. 3A). 
Fig. 2. The predicted position of cysteines in the homology model of T. roseopersicina SqrF protein. The protein backbone atoms are shown in cartoon ribbon format 
(white/grey). Cys residues (labelled) and FAD cofactor are shown in stick representation, coloured by atom type (C are green, O red, N blue, H white, S yellow and 
P brown). 
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3.3. Spectroscopic analysis of the pure cysteine mutant TrSqrFs 
Mutant proteins “as isolated” were used for recording their absorp-
tion spectra. Since the purification was performed aerobically, and even 
the samples were stored under air, it is feasible to suppose that the en-
zymes were in oxidized form. The FAD containing proteins, such as 
TrSqrF, can be investigated by UV–visible absorption spectroscopy. 
Proteins having FAD-binding sites and are in oxidized form will give two 
characteristic absorption peaks at 360 nm and 448 nm (Fig. 4A) [16]. 
However, if the reduced form of FAD is present only, no peaks will be 
detected (Fig. 4A). The recorded absorption spectrum for a FAD-binding 
protein will give a peak profile that reflects the cumulative redox state of 
the FAD in the enzyme samples. Comparative analysis of the UV–Vis 
spectra of the wild-type and cysteine mutant TrSqrF proteins (Fig. 4B) 
shows that all variants, except the C121A mutant protein, contain FAD 
cofactor, proven by the absorption shoulder at 360 nm and a peak at 
448 nm. A broad absorption band at around 675 nm has also appeared in 
the spectra of the wild type, C49A and C272A mutants. This indicates 
the presence of charge-transfer complex (CTC) between the FAD and 
thiolate in these proteins as reported in other SQRs [28,52] and Type II 
NADH:quinone oxidoreductase of Staphylococcus aureus [53,54], which 
enzymes are all members of the two-Dinucleotide Binding Domains 
Flavoprotein (tDBDF) superfamily. Based on the absorption spectra, 
FAD-protein ratios of the purified C49A, C272A and C332A TrSqrF 
variants were as follows: 0.85, 0.7 and 0.92, respectively. These values 
are similar to that of the wild type protein (0.83). In the case of the 
spectrum of the C121A mutant, the peak at 448 nm is missing, indicating 
the lack of FAD in the protein. Sequential reduction and oxidation of the 
C121A mutant with dithionite and then duroquinone (applied similarly 
as for the wild-type TrSqrF (Fig. 4A)) did not affect the absorption 
spectrum of this mutant. This observation further justifies that the 
C121A protein does not contain FAD cofactor (data not shown). FAD 
cofactor content was also studied with UV illumination of the SDS-PAGE 
gel of the purified TrSqrF variants (Fig. 3B). The fluorescent signal of 
FAD was not detectable in the C121A variant in contrast to the other 
cysteine mutant proteins, indicating that FAD binds to all mutant pro-
teins excepting C121A variant (Fig. 3B). Differences in the absorption 
spectra of the purified TrSqrF mutants, focusing on the 400 nm to 500 
nm wavelength range are also informative concerning the redox states of 
the TrSqrF variants (Fig. 4B). The absorption spectrum of the C332A 
sample has a profile indicating that the covalently bound FAD is 
oxidized in most of the protein populations. In the wild type, C49A and 
C272A TrSqrF mutants, a proportion of the protein contain reduced FAD 
(Fig. 4B). The reduction of FAD in these proteins is also supported by the 
presence of absorption peak characteristic of CTC. Note, that in these 
absorbance spectra, an additional peak at 408 nm was visible. This peak 
is attributed to the presence of trace amounts of cytochrome c in some 
samples (the extinction coefficient of the heme group at this wavelength 
is 170 mM− 1 cm− 1 [55]). The amount of c-type cytochrome is insub-
stantial compared with the quantity of TrSqrF in the samples. Addi-
tionally, in the SDS-PAGE gel of eluted proteins only one single band was 
found, verifying the purity of TrSqrF variants and the low concentration 
of cytochrome c content in the purified protein samples (Fig. 3A). 
A
B













KDa WT          C49A      C121A      C272A     C332A
Fig. 3. Denaturing SDS-PAGE analysis of the wild type and single cysteine 
mutant TrSqrF protein samples expressed and purified from T. roseopersicina. 1 
μg proteins were loaded. Standard molecular weight markers are in the first 
lane. A) Blue silver-stained SDS-PAGE gel. B) The same unstained SDS-PAGE gel 
illuminated by UV light to detect the fluorescent signal from FAD. 
Fig. 4. UV–vis absorption spectra of the purified wild-type and mutant TrSqrF proteins. A) Spectra of the “as isolated” (solid line), dithionite (1 mM) reduced (dashed 
line) and duroquinone (100 μM) oxidized (dot-dashed line) TrSqrF. B) UV–vis spectra of the purified wild-type and single cysteine mutant C49A, C121A, C272A and 
C332A TrSqrF variants (21.5 μM, 26.3 μM, 5.2 μM, 16.3 μM and 21.8 μM, respectively), with the colour key provided. For better comparability, the absorption 
spectra were normalized to the same maximum absorption value. 
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3.4. Enzyme activity and kinetic parameters of wild type and cysteine 
mutant TrSqrF variants 
In our previous paper, we presented the sulfide-dependent quinone 
reducing activity of the wild type TrSqrF using various quinones [16]. 
This study indicated the ubiquinone-type compounds such as dur-
oquinone and decylubiquinone are good substrates as final electron 
acceptors for this SQR. Due to its favourable solubility properties, dur-
oquinone was chosen as the substrate for the TrSqrF variants. The 
sulfide-dependent duroquinone reducing activities of the cysteine 
mutant TrSqrF enzymes were measured at 25 ◦C in a standard activity 
assay (see Section 2.8) and compared to that of the wild type enzyme. 
The C49A mutant has slightly higher specific activity (1.03 ± 0.09 U 
mg− 1) than TrSqrF (0.96 ± 0.16 U mg− 1). The C121A variant has no 
activity which might be due to the lack of FAD in this enzyme. The 
C272A mutant has marginally reduced specific activity (0.82 ± 0.08 U 
mg− 1) while the specific activity of the C332A mutant protein is 
remarkably diminished (0.14 ± 0.03 U mg− 1) as compared to the TrSqrF 
enzyme activity (Fig. 5). 
A steady-state kinetic study of the mutant versus wild-type enzymes 
can be somewhat more informative for the comparative analysis of ac-
tivity, and the potential reasons for it, than specific activity measure-
ments. The steady-state kinetic curves of cysteine mutant enzymes for 
sulfide and duroquinone substrates were thus measured (Fig. S3) and the 
data were fitted to the Michaelis-Menten equation by non-linear 
regression to derive the Km, kcat and kcat/Km kinetic parameters 
(Table 1). The C121A mutant was not active, and hence no kinetic pa-
rameters are reported for this enzyme. The C49A enzyme has slightly 
increased Vmax and kcat values as compared to those of wild-type TrSqrF. 
However, a higher Km for sulfide, suggests that the replacement of Cys49 
with alanine has caused decreased affinity for the sulfide substrate. It 
displays no detectable change in affinity for the dUQ substrate. The kcat 
of the C272A variant slightly decreased, and the affinity of the C272A 
mutant for duroquinone (DQ) was lower (increased Km) than those of the 
wild-type TrSqrF enzyme, but the mutated enzyme has a similar affinity 
for the sulfide substrate. Overall, this variant has a very similar speci-
ficity for sulfide to the wild type enzyme but lower specificity with the 
DQ substrate than wild type TrSqrF. Results with the C332A mutant 
TrSqrF variant are immediately more evident than the C49 and C272 
mutations. The kcat and the Vmax values for the C332A variant catalyzed 
reaction were each one order of magnitude smaller than those data 
obtained with the wild type enzyme which coincided with the signifi-
cantly diminished specific activity measured for this mutant enzyme 
(Table 1 and Fig. 5). 
In the statistic analysis, significance values were calculated by 
Welch’s t-test in R Studio software; single and double asterisks indicate 
p-value < 0.05 and p-value < 0.005, respectively. The p-value repre-
sents the probability that the difference between the experimental data 































Fig. 5. Sulfide-dependent duroquinone-reducing activity of purified wild type 
and single cysteine mutant TrSqrF variants. 
Table 1 
Steady-state kinetic parameters of the wild type [16] and the cysteine mutant 
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Fig. 6. The activities of the wild type and single cysteine mutant TrSqrF variants in the presence of IAA sulfhydryl reagent.  
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3.5. Inhibition of duroquinone reducing activity of wild type and cysteine 
mutant TrSqrF variants 
To further study the role of the cysteines in the catalytic mechanism 
of TrSqrF, iodoacetamide (IAA) and iodoacetic acid were used as sulf-
hydryl blocking agents. The inhibition of TrSqrF by these reagents was 
followed using standard enzyme activity measurements [16]; in these 
cases, the sulfhydryl reagent was added to the reaction mixture con-
taining active enzyme. IAA proved to be a better blocking agent, and the 
inhibition of mutant enzymes was assessed using this reagent. The 
duroquinone-reducing activity of the wild-type TrSqrF is completely 
inhibited by 300 μM IAA [16]; the IC50 value of the IAA reagent was 134 
μM. The inhibitory effect of the reagent on the inactive C121A mutant 
TrSqrF was not measured. The inhibition level of the C49A mutant was 
similar to that of the wild type enzyme (IC50 = 131 μM). However, for 
C272A, variant was inhibited by less, 150 μM blocking agent (IC50 = 86 
μM.). Finally, the C332A was much more sensitive to inhibition with IAA 
(with an IC50 = 15 μM) (Fig. 6). This more ready inhibition of C332A 
with IAA correlates with its overall decreased enzyme activity. 
In the following experiments, we asked whether a resting enzyme 
can be blocked/inhibited by the sulfhydryl reagent. The enzymes were 
incubated in the presence and absence of IAA applied in higher amount 
(500 μM) than minimal inhibitory concentration for 10 min at 25 ◦C. 
Samples containing 3.3 μg enzymes were taken from the mixtures, and 
their duroquinone-reducing activities were determined using standard 
activity assay. It should be noted that the activity assay reaction mixture 
contained 1.3 μM IAA after transfer with treated enzyme sample and 
dilution within the assay mix. Thus, the remaining concentration of IAA 
in the activity assay was two orders of magnitude lower than the IC50 
value of this agent. On comparison of activity measurements recorded 
using TrSqrF, and TrSqrF that has been pretreated with IAA, as above, it 
is important to note, that the activities were identical, suggesting that 
the wild type resting enzyme was not inactivated in the presence of IAA 
(Fig. 7A). However, the duroquinone-reducing activity of the TrSqrF 
protein previously preincubated with 500 μM IAA in the presence of the 
substrates, duroquinone (50 μM) and sulfide (200 μM), was markedly 
decreased to 68.5 ± 9.1%, of the normal levels, indicating that a portion 
of enzyme molecules was inactivated by such treatment (Fig. 7B). After 
the IAA treatment, UV–Vis spectra of these samples were recorded. The 
spectrum of the TrSqrF protein preincubated with substrates in the 
presence of IAA gives a slightly higher peak at 448 nm, compared to a 
sample without IAA, suggesting that, in the presence of IAA inhibitor, a 
greater proportion of the enzyme contains oxidized FAD (Fig. 7C). The 
inactivation effect of IAA on TrSqrF protein would appear to require the 
presence of substrates, and thus is only exerted on enzyme molecules 
that are undertaking catalysis (Fig. 7A and B). 
As part of the inhibition studies, the FAD-binding to IAA-inhibited 
enzyme was studied. Samples of TrSqrF proteins previously treated in 
the presence of the substrates were precipitated with 5% trichloroacetic 
acid then centrifuged. The precipitated protein was collected in yellow 
pellets indicating the presence of FAD in these samples. The pellets were 
suspended and filtered (see in Section 2.9) to separate the released FAD 
cofactors from TrSqrF proteins. Absorption spectroscopy was then used 
to monitor the presence of FAD, if released from the enzyme, in the 
filtrate. Two absorption peaks at 360 and 448 nm indicate the presence 
of FAD in the filtrate for the TrSqrF protein sample preincubated with 
substrates and IAA (F of TrSqrF (Na2S + DQ + IAA) in Fig. 7C but these 
peaks are not observed for the filtrate of the non-inhibited control pro-
tein sample (F of TrSqrF (Na2S + DQ)). The results show that FAD is 
released from the enzyme in the IAA-treated sample (of which some 
inactivation occurs) but is not released from the non-inhibited sample, 
presumably remaining covalently bound in the TrSqrF enzyme (Fig. 7C). 
These data suggest that the covalent bond between the catalyzing 
enzyme and FAD got temporarily broken, allowing the binding the 
sulfhydryl reagent and thus releasing the cofactor. 
4. Discussion 
This study has focused on the catalytic function of cysteine residues 
in the type VI SqrF enzyme of one of the most widely studied species of 
purple sulfur bacteria, Thiocapsa roseopersicina. Despite the structural 
similarity, there are significant variations among the representatives of 
the six types of SQR enzymes in their primary sequences and kinetic 
properties [15,17,19,21,23,25,27,52,56–59], which likely results in 
possible differences in the catalytic mechanisms of various type of SQRs. 
Type VI SQRs are remarkably divergent, as discussed further later. Based 
on structural, biochemical and site-directed mutagenesis studies, a few 
alternative models of catalytic mechanism have been proposed for SQRs 
in groups outside type VI [12]. The proposed models are concordant in 
the essential role of conserved cysteines located in the active site in the 
enzymatic process. Two of the conserved cysteines form a disulfide 
bridge which is the redox-active centre in the catalytically active site, 
similarly to other members of the FDR enzyme family [14]. The models 
assume that cysteines in equivalent positions to the Cys156 and Cys347 
Fig. 7. Inhibition of TrSqrF by sulfhydryl blocking agent IAA. Relative activities of enzyme samples treated in the absence (A) and the presence (B) of sulfide and 
duroquinone substrates. (C) Absorption spectra of the samples from assays shown in panel B. Abbreviations: TrSqrF and TrSqrF (Na2S + DQ): non-treated controls, 
TrSqrF IAA and TrSqrF (Na2S + DQ + IAA) are samples pretreated by iodoacetamide in the absence and presence of the substrates, respectively. F designates the 
filtrate of the indicated samples (see also the text). 
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residues of the A. aeolicus SqrA protein are candidates for the formation 
of the essential disulfide bond in SQRs. However, it is not possible to 
directly observe a disulfide bridge between these cysteines in the SQR 
structure. The distance between these residues is 8.31 Å and 8.8 Å in the 
SqrA enzymes of A. aeolicus and A. ferrooxidans, respectively [24,26], 
which are too long for the formation of direct disulfide bonds between 
these amino acids and it is proposed these cysteines are connected by 
polysulfur chains which are synthesized in the repeating catalytic cycles 
of the sulfide oxidation reaction. The equivalent residues of Cys347 are 
positioned in a conserved β-strand structure that forms part of the 
enzyme active site inside the protein [22,24–26]. However, the Cys156 
(and its equivalents in homologous enzymes) is located in a loop region 
of the A. aeolicus SqrA protein [24]. Thus, the relative spatial location of 
the amino acid is probably flexible in the active site. At the beginning of 
the catalytic process, they may be located closer to each other, forming a 
disulfide bond which reacts with the sulfide substrate in the first reac-
tion cycle. The third conserved cysteine is the homologue of the Cys124 
of A. aeolicus SqrA. This residue is connected to FAD in some SQR en-
zymes, binding the cofactor covalently by thioether or persulfide bonds 
[24,25] and might also be able to form a disulfide bridge with the 
equivalents of the Cys156 residue during catalysis [24]. 
In terms of the primary and spatial structural pattern of conserved 
cysteines, the type VI SQRs show the most massive difference as 
compared to other SQR enzymes. These enzymes are typically found in 
bacteria that may live in environments exposed to high levels of sulfide 
[12,21]. Accordingly, the Km values (for sulfide) of kinetically charac-
terized SqrF enzymes of C. tepidum [21] and T. roseopersicina [16] are 
significantly higher than most other SQRs in other groups. Such differ-
ences between the type VI SQRs and other types indicate that a distinct 
reaction mechanism in typeVI SQR enzymes is possible. The TrSqrF 
protein contains four cysteines, all of which are investigated in our 
study; only two of these are also present in other SQR types: Cys121 and 
Cys332 equivalent to Cys124 and Cys 347 of A. aeolicus respectively 
(Fig. 1). Critically, an equivalent to Cys156 is not present in TrSqrF (or 
other members of type VI SQRs), and it would therefore appear that the 
proposed disulfide bridge that requires this residue in existing models of 
catalysis cannot form in enzymes of this group. However, type VI SQR 
proteins contain a conserved cysteine that is exclusive to this group 
(Cys272). Moreover, the TrSqrF also has a cysteine (Cys49) that is not 
conserved across type VI enzymes. Both these cysteines were included in 
our studies concerning the possible participation in catalysis. Conser-
vation of a cysteine at the position equivalent to Cys124 would suggest 
that the location of this cysteine is critical to catalysis in all SQR types, 
regardless of the precise mechanism, presumably via interaction with 
FAD. Indeed, the wild type TrSqrF protein binds FAD covalently [16], 
similarly to SqrA of A. aeolicus and SqrE of A. ambivalens [24,25]. 
Our homology model of the TrSqrF protein allows us to inspect a 
proposed structure in the absence of a crystal structure. As expected, 
Cys121 and Cys332 are in the active site of the enzyme, close to the FAD 
cofactor (Fig. 2). In the minimized homology model, the distance be-
tween the sulfur of the side chain of Cys121 and the C8M atom of the 
isoalloxazine ring is 1.82 Å, which is sufficient for the formation of a 
covalent connection. In contrast, the Cys332 Sγ atom was found at 5.81 
Å from the C4A atom of the redox moiety of the FAD cofactor. According 
to the homology model, Cys272 and Cys49 residues are located near the 
surface of the protein, not in the active site. The distance between the 
cysteines of the active site (Cys121 and Cys332) was found to be too long 
for the formation of a disulfide bridge. Furthermore, the surface local-
ized cysteines are also unable to connect to either of the active site 
cysteines because of their inter-residue distances that exceed 15 Å in 
every case. Therefore, the homology model confirmed our earlier 
proposition, based solely on primary sequence analysis, that a disulfide 
bridge between cysteines cannot occur in type VI SQRs. Indeed, a bio-
informatic classification of SQRs excluded type VI enzymes from the 
sulfide:quinone oxidoreductase family, mostly due to the absence of 
Cys156, conserved across all other types (Fig. 1) [6]. Our homology 
model supports that neither Cys272 nor Cys49 in TrSqrF can fulfil the 
role of the missing equivalent to Cys156. Nevertheless, biochemical 
characterization of two representatives of the type VI SQRs justifies that 
these proteins have sulfide:quinone reductase activity [16,21]. It is thus 
of high interest to determine how the type VI SQRs catalyze a sulfide: 
quinone reductase reaction. 
Focusing on the roles of cysteines of type VI SQRs in the catalytic 
reaction mechanism, we employed site-directed mutagenesis to create 
and characterize single alanine mutants for each of the four cysteines. 
The obvious candidate cysteine in TrSqrF for forming a covalent linkage 
to the FAD is Cys121 (equivalent to Cys124 in A. aeolicus). Indeed, the 
change of the Cys121 residue to alanine resulted in an enzyme unable to 
bind FAD and loss of activity. The distance between the side chain S 
atom of Cys121 and the C8M group of the isoalloxazine ring is small 
(1.82 Å) which is suitable for the formation of a thioether bond, similar 
to that of the type V SQR of A. ambivalens [25]. It was also examined 
whether the structure allows accommodation of more than one sulfur 
atom between the FAD and the protein as seen in the structure of SqrA of 
A. aeolicus [24]. Inspection of our modelled structure found that there is 
enough space for inserting a second sulfur atom to form a persulfide 
bond (Fig. S1), as Cys121 is located within a sizeable, flexible loop re-
gion (residues 108–125) (Fig. S2), and mobility of the flexible loop could 
allow easy insertion of an extra atom. More precisely, the distance be-
tween the central carbon atom of the methyl group of the flavin ring and 
the Cα of the Cys121 changes from 3.39 Å to 3.89 Å if a second sulfur 
incorporates for persulfide bond formation. This spatial shift can be 
realizable by the long loop. Of note, though, it is worth pointing out that, 
although this loop naturally quite flexible, the local environment of 
Cys121 (Thr119 - Pro120 - Cys121 - Glu122) indicates a β-turn in this 
region stabilized by two structural elements. On one side, there is a weak 
H-bond between the backbone carboxyl group of the Thr119 and NH 
group of Glu122 retained whether one or two sulfurs are accommo-
dated. On the other side, the Pro120 also promotes the formation of the 
turn. We propose this local β-turn structure could help direct the 
connection between the Cys121 and the FAD cofactor. Interestingly, this 
is the first report of a cysteine in this position being absolutely required 
for FAD binding; while the absence of FAD in C128A and C127S mutant 
SqrA proteins of A. ferrooxidans and R. capsulatus, respectively, was not 
reported [17,18]. 
We employed site-directed mutagenesis to create and characterize 
single alanine replacement mutants for each of four cysteine residues of 
TrSqrF. Indeed, due to the replacement of the Cys121 to Ala, the protein 
lost the FAD cofactor, indicating the essential role of this cysteine in 
cofactor binding. This experimental result clearly confirms the feasi-
bility of our homology model, but of course, cannot exclude indubitably 
the possibility of an entirely differently folded protein. In the other 
cysteine mutants, the FAD was strongly associated with the protein. The 
C121A mutant TrSqrF enzyme had no sulfide-dependent quinone 
reductase activity, which proved that Cys121 is essential for catalysis. 
Furthermore, the absence of the redox cofactor in this enzyme form 
results in the loss of function of this mutant. The C332A mutation caused 
a remarkable decrease in enzyme activity but did not completely inac-
tivate the enzyme, indicating that this residue is necessary but not 
essential in the catalytic process. This residual activity might be 
considered surprising since mutants of the equivalent Cys356 and 
Cys353 residues of type I SQR of A. ferrooxidans and R. capsulatus and 
Cys344 cysteine of type II SQR of Staphylococcus aureus, respectively, are 
entirely inactive [17,18,23]. Furthermore, the studied C332A mutation 
had no significant effect on the Km of sulfide and quinone. This suggests 
that the conserved cysteine, participates in the catalytic process but it 
has no direct role in the binding and interaction with the substrates 
(sulfide and quinone compounds) in type VI SQRs. Notably, this might 
be the corresponding cysteine to Cys347 in A. aeolicus, which forms the 
disulfide active redox centre that is part of the mechanistic models for 
catalysis by this enzyme. The partner cysteine, as already mentioned 
herein, is lacking in TrSqrF (a cysteine equivalent to Cys156) and 
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another type VI enzymes, uniquely in the SQR family. Hence, although 
involved in optimizing catalysis, Cys332 in TrSqrF cannot participate in 
the mechanisms as thus far proposed. All purified C332A mutants are 
oxidized with respect to bound FAD, suggesting that Cys332 participates 
in the reductive (sulfide oxidation) phase of the catalytic cycle. The 
demonstrated proximity of Cys332 to FAD would favour this proposal 
(FAD becomes reduced in this stage). The lack of the absorption peak 
characteristic for CTC in SQR enzymes in the spectra of C121A and 
C332A mutants also supports the role of these cysteines in the sulfide 
oxidation process. 
Cys272 is a cysteine that is not present in other types of SQRs and 
might be a candidate for participation in catalysis in place of an 
equivalent residue to Cys156. Modification of Cys272 specific for the 
type VI SQRs slightly decreased the activity of TrSqrF and affected the 
Km of duroquinone, indicating a reduced affinity for the quinone sub-
strate. These observations confirm that Cys272 does not perform a role 
equivalent to the missing Cys156, but indicate that the residue, located 
close to the protein surface participates in the quinone reduction step of 
the enzyme reaction. In the TrSqrF protein, the Met156 residue is 
located in the analogous sequence and spatial position as Cys156 in SqrA 
of A. aeolicus. A single mutant variant of TrSqrF enzyme, in which this 
residue was changed to alanine, was also created. The specific activity of 
the M156A mutant was 1.18 ± 0.376 μmol min− 1 mg− 1, which did not 
differ significantly from the activity of the wild-type TrSqrF, indicating 
that this methionine does not participate in the enzyme catalysis. Mu-
tation of Cys49 resulted in an enzyme with equivalent, or slightly 
enhanced activity as compared to the wild-type TrSqrF, and with a slight 
reduction in affinity to sulfide. The position of this cysteine, well away 
from the active site, would imply that the small effects caused by its 
mutation are indirect and mediated, for example, by slight perturbations 
in protein structural stability. 
The effect of the sulfhydryl-group reacting agents iodoacetamide 
(IAA) and iodoacetic acid on the TrSqrF enzyme was also investigated. 
The relative activity of TrSqrF was lower in the presence of both of these 
enzyme inhibitors, as observed for other SQRs [5,19,25]. However, 
TrSqrF enzyme samples treated with IAA in the absence of substrate 
molecules were not inhibited, showing that IAA can react with the 
active/catalyzing but not resting protein. According to our assumption, 
IAA blocks the catalytic process of the enzyme by reacting with cysteine 
(s) for which the thiol-group is would usually be inaccessible (e.g. in a 
bound form) in non-catalyzing protein. To explain irreversible inhibi-
tion of a proportion of enzyme by IAA in the presence of substrates, a 
cysteine can move from a bound to an unbound (free) form during the 
catalytic process. In this state, the free sulfhydryl-group of the cysteine 
can react with IAA forming an irreversibly modified enzyme that cannot 
complete the catalytic cycle. Based on the structural model of TrSqrF, 
only the Cys121 can be in a covalently bound form in the protein. 
Moreover, the presence of FAD was detected in the supernatant of IAA- 
inactivated denatured enzyme samples, indicating the release of the 
cofactor from the inhibited enzyme. It confirms our assumption that 
inhibition of TrSqrF is caused by the reaction of IAA with the Cys121 
residue, presumably responsible for the covalent binding of the FAD 
cofactor. Probably the covalent bond between the cysteine and cofactor 
is broken at specific points during the catalytic process allowing the 
reaction of IAA with the thiol-group of Cys121. In the absence of sub-
strates, Cys121 would be covalently linked to FAD permanently, and the 
linkage would not be disrupted; hence, IAA does not cause irreversible 
enzyme inhibition. Another challenging point concerns the Cys332 
residue. The C332A mutation led to dramatically reduced enzyme ac-
tivity. As discussed above, this cysteine cannot be bound to other cys-
teines via a disulfide bridge; therefore, theoretically, it should be in thiol 
form. However, IAA does not block this residue in the resting enzyme 
indicating Cys332 in a form preventing the reaction with IAA. It is 
reasonable to assume that Cys332 takes over the polysulfur chain from 
Cys121 and thus, it cannot react with IAA. 
Determination of the inhibitory concentration values of IAA for the 
C49A, C272A and C332A TrSqrF variants showed that the cysteine 
mutants, which have decreased activity relative to the wild type, could 
be inhibited by lower concentrations of IAA even though the protein 
contains fewer cysteines than the wild type enzyme. The C272A mutant 
is less, while the C332A variant is more sensitive to IAA dependent 
enzyme inhibition. These results also suggest that the thiol group of the 
cysteine(s) participating in the catalytic process is in a free state in part 
of the catalytic cycle. In single cysteine mutant TrSqrF variants showing 
decreased activity, especially in the C332A variant, the probability of 
the reaction of IAA with the free cysteine sulfhydryl-group is higher 
because of the time of the free-thiol, iodoacetamide reactive state of 
Cys121 is likely longer in a slower catalytic cycle. 
Fig. 8. A mechanistic model for catalysis of sulfide oxidation by the type VI sulfide:quinone oxidoreductase enzyme of T. roseopersicina based on recent biochemical 
analysis of wild-type and single cysteine mutant SqrF variants. In the first reaction cycle of a resting enzyme, sulfide attacks the Cys121-C8M persulfide bridge to form 
a Cys121 thiolate and a persulfide on the C8M methyl moiety of the isoalloxazine group of FAD as the charge transfer complex to transfer two electrons from the 
bound sulfide substrate to the isoalloxazine ring. The next step is the re-formation of the covalent bond between Cys121 and the cofactor, as a trisulfide bridge, and 
the regeneration of oxidized enzyme by reduction of the final electron acceptor quinone compound. In the following reaction cycles, each sulfide attacks the pol-
ysulfide chain bound to the cofactor connecting to the isoalloxazine ring to create the charge-transfer complex. Finally, each sulfur (oxidized sulfide) is incorporated 
into the polysulfide formed between the Cys121 and FAD. Cys332 may have a role in taking over the sulfur chain from the active centre of enzyme allowing to restore 
the sulfide non-binding enzyme form. 
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According to the catalytic mechanism models of SQR enzymes, the 
redox-active disulfide bond between the conserved cysteines of the 
active site is broken by sulfide substrate. In the previously proposed 
mechanisms, the cysteines (Cys356, Cys156 and Cys178 in SqrA en-
zymes of A. ferrooxidans, A. aeolicus and SqrE of A. ambivalens, respec-
tively) participates in the generation of an electron transfer transient 
covalent adduct with the isoalloxazine ring of FAD. The other cysteines 
(Cys160, Cys350 and Cys347 in A. ferrooxidans, A. aeolicus and 
A. ambivalens, respectively) will be in a free state [24–26]. Since C332A 
in TrSqrF is not IAA-reactive in the resting enzyme, it might not be in a 
free thiol state but might contain a polysulfur adduct. 
Our structure-function analysis of cysteine residues in TrSqrF 
enabled us to construct a model for FAD cofactor binding and the 
mechanism of sulfide oxidation in type VI SQR enzymes to be proposed 
(Fig. 8). In this model, the Cys121 residue is responsible for the covalent 
binding of FAD by a putative persulfide-bridge between the cysteine and 
the C8M methyl-group of the isoalloxazine ring, similarly to the FAD- 
binding reported in the SqrA of A. aeolicus [24]. Presumably, this het-
erodisulfide bond is the usual redox-active centre of the type VI SQR 
enzyme. In the first step of the catalytic cycle, the sulfide substrate reacts 
with the persulfide structure and binds to the Cys121 sulfur which 
directly connects to the C8M moiety of the isoalloxazine ring, forming a 
charge-transfer complex with FAD, allowing the transfer of two elec-
trons from the reduced sulfur to the cofactor. Due to the concomitant 
opening of the heterodisulfide bond, the free thiol-group of Cys121 is 
formed, capable of reacting with sulfhydryl-blocking reagents (such as 
iodoacetamide). After the oxidation of the FAD via electron transfer to a 
quinone molecule, Cys121 gets probably connected to the cofactor 
again, reforming the heterodisulfide bridge through an extended form 
(polysulfide) that incorporates of the oxidized sulfide into the sulfur 
chain. In the next catalytic cycle, a new sulfide molecule attacks the 
sulfur connected to the cofactor. The role of Cys332 in the catalysis of 
sulfide oxidation has yet to be clarified. While our kinetic data do not 
implicate C332A in substrate binding (which fits with our model), this 
conserved cysteine might participate in taking over the polysulfur chains 
of oxidized sulfides. This suggestion would fit with our kinetic data and 
inhibition study and corresponds to the proposed function of Cys347 in 
A. aeolicus SqrA [12,24]. 
The model, presented here, is the result of the first mechanistic study 
of a type VI SQR enzyme and, as such, it is both unique and unprece-
dented. It validates this group as bona fide SQRs, despite their exclusion 
in the bioinformatic classification of SQRs based on sequence conser-
vation [6]. The model is attractive because the need for a second 
cysteine to form a disulfide bond, as proposed in the mechanism of other 
SQR types, is negated by the use of sulfur from the sulfur-rich environ-
ment of the host bacterium. 
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